Engaging Physicians in Cost Savings Initiatives: Eliminating Medication Cost Bias in the Selection of Inpatient Medications (Resource Management‪)‬

Higher cost medications or therapeutic regimens pose a serious question for physician executives and other hospital managers who must determine if the cost/benefit ratio of a newer technology drug helps the organization achieve its value proposition of providing optimal care. Even when a hospital has robust data, engaging physicians to help with these decisions is often an elusive goal. The stakes are increasing as we move from routine antibiotic choices to evaluation of new, and often expensive, biotechnology-based medications or devices, some with costs that can run into thousands of dollars.